Medicus Pharma Ltd.
MDCX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -250.38% | -274.22% | -352.79% | -297.34% | -76.54% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -100.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,680.81% | 2,104.40% | 2,164.12% | 9,343.19% | -47.82% |
| Change in Net Operating Assets | 48.07% | -354.63% | 1,631.91% | 116.19% | -35.06% |
| Cash from Operations | -86.71% | -113.70% | -122.27% | -85.36% | -109.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 552.58% | 129.41% | 129.41% | 129.41% | -13.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 165.19% | 205.04% | 275.74% | 299.06% | 21.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -198.75% | -2,960.80% | -- | -- | -- |
| Cash from Financing | 191.07% | 112.79% | 151.65% | 156.86% | 7.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,130.53% | -30.73% | 85.71% | 1,592.33% | -84.73% |